_id

690db5deccc777a4e85d0dea

Ticker

BCLI

Name

Brainstorm Cell Therapeutics Inc

Exchange

NASDAQ

Address

1325 Avenue of Americas, New York, NY, United States, 10019

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.brainstorm-cell.com

Description

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Last Close

0.59

Volume

24590

Current Price

0.55

Change

-6.77966101694914

Last Updated

2025-11-28T12:45:53.007Z

Image

data:image/webp;base64,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

Ipo Date

2003-08-28T00:00:00.000Z

Market Cap

6841561

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4

Target Price

20.675

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

2047000

Operating Income

-2047000

Interest Expense

-

Pretax Income

-2106000

Net Income

-2106000

Eps

-0.19085119542537116

Dividends Per Share

-

Shares Outstanding

11034775

Income Tax Expense

-

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

-

Cash

5000

Short Term Investments

-

Receivables

80000

Inventories

-

Total Current Assets

508000

Property Plant Equipment

617000

Total Assets

872000

Payables

6420000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

50000

Equity

822000

Depreciation

48000

Change In Working Capital

799000

Cash From Operations

-1102000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

313000

Net Change In Cash

-789000

PE

-

PB

7.3833652676399035

ROE

-256.2043795620438

ROA

-241.5137614678899

FCF

-1102000

Fcf Percent

-

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3

Defensive Investing Score

5.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

2047000

Quarters > 0 > income Statement > operating Income

-2047000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-2106000

Quarters > 0 > income Statement > net Income

-2106000

Quarters > 0 > income Statement > eps

-0.19085119542537116

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

11034775

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-

Quarters > 0 > balance Sheet > cash

5000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

80000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

508000

Quarters > 0 > balance Sheet > property Plant Equipment

617000

Quarters > 0 > balance Sheet > total Assets

872000

Quarters > 0 > balance Sheet > payables

6420000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

50000

Quarters > 0 > balance Sheet > equity

822000

Quarters > 0 > cash Flow > net Income

-2106000

Quarters > 0 > cash Flow > depreciation

48000

Quarters > 0 > cash Flow > change In Working Capital

799000

Quarters > 0 > cash Flow > cash From Operations

-1102000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

313000

Quarters > 0 > cash Flow > net Change In Cash

-789000

Quarters > 0 > ratios > PE

-0.19085119542537116

Quarters > 0 > ratios > PB

7.3833652676399035

Quarters > 0 > ratios > ROE

-256.2043795620438

Quarters > 0 > ratios > ROA

-241.5137614678899

Quarters > 0 > ratios > FCF

-1102000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

2573000

Quarters > 1 > income Statement > operating Income

-2573000

Quarters > 1 > income Statement > interest Expense

330000

Quarters > 1 > income Statement > pretax Income

-2903000

Quarters > 1 > income Statement > net Income

-2903000

Quarters > 1 > income Statement > eps

-0.3367593151129878

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

8620400

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-2522000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-330000

Quarters > 1 > balance Sheet > cash

824000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

106000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

1515000

Quarters > 1 > balance Sheet > property Plant Equipment

826000

Quarters > 1 > balance Sheet > total Assets

2566000

Quarters > 1 > balance Sheet > payables

5997000

Quarters > 1 > balance Sheet > short Term Debt

482000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

8623000

Quarters > 1 > balance Sheet > equity

-6057000

Quarters > 1 > cash Flow > net Income

-2903000

Quarters > 1 > cash Flow > depreciation

51000

Quarters > 1 > cash Flow > change In Working Capital

-1153000

Quarters > 1 > cash Flow > cash From Operations

-3502000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

2701000

Quarters > 1 > cash Flow > net Change In Cash

-801000

Quarters > 1 > ratios > PE

-0.3367593151129878

Quarters > 1 > ratios > PB

-0.7827670463926037

Quarters > 1 > ratios > ROE

47.92801717021628

Quarters > 1 > ratios > ROA

-113.13328137178489

Quarters > 1 > ratios > FCF

-3502000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

52000

Quarters > 2 > income Statement > gross Profit

-52000

Quarters > 2 > income Statement > operating Expenses

3089000

Quarters > 2 > income Statement > operating Income

-3089000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-2864000

Quarters > 2 > income Statement > net Income

-2864000

Quarters > 2 > income Statement > eps

-0.45159255755282246

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

6342000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-3037000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

225000

Quarters > 2 > balance Sheet > cash

1644000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

67000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

2332000

Quarters > 2 > balance Sheet > property Plant Equipment

1035000

Quarters > 2 > balance Sheet > total Assets

3571000

Quarters > 2 > balance Sheet > payables

6797000

Quarters > 2 > balance Sheet > short Term Debt

1643000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

11028000

Quarters > 2 > balance Sheet > equity

-7457000

Quarters > 2 > cash Flow > net Income

-2864000

Quarters > 2 > cash Flow > depreciation

52000

Quarters > 2 > cash Flow > change In Working Capital

643000

Quarters > 2 > cash Flow > cash From Operations

-1631000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

3086000

Quarters > 2 > cash Flow > net Change In Cash

1455000

Quarters > 2 > ratios > PE

-0.45159255755282246

Quarters > 2 > ratios > PB

-0.4677618345179027

Quarters > 2 > ratios > ROE

38.40686603191632

Quarters > 2 > ratios > ROA

-80.20162419490339

Quarters > 2 > ratios > FCF

-1631000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

849000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

633000

Quarters > 3 > income Statement > operating Expenses

3189000

Quarters > 3 > income Statement > operating Income

-3189000

Quarters > 3 > income Statement > interest Expense

66000

Quarters > 3 > income Statement > pretax Income

-2973000

Quarters > 3 > income Statement > net Income

-2973000

Quarters > 3 > income Statement > eps

-0.5208375305748975

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

5708114

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-3136000

Quarters > 3 > income Statement > operating Margin

-375.6183745583039

Quarters > 3 > income Statement > total Other Income Expense Net

216000

Quarters > 3 > balance Sheet > cash

187000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

63000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

385000

Quarters > 3 > balance Sheet > property Plant Equipment

1241000

Quarters > 3 > balance Sheet > total Assets

1832000

Quarters > 3 > balance Sheet > payables

6080000

Quarters > 3 > balance Sheet > short Term Debt

549000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

9596000

Quarters > 3 > balance Sheet > equity

-7764000

Quarters > 3 > cash Flow > net Income

-2973000

Quarters > 3 > cash Flow > depreciation

53000

Quarters > 3 > cash Flow > change In Working Capital

1946000

Quarters > 3 > cash Flow > cash From Operations

-1048000

Quarters > 3 > cash Flow > capital Expenditures

1683000

Quarters > 3 > cash Flow > cash From Investing

12000

Quarters > 3 > cash Flow > cash From Financing

1058000

Quarters > 3 > cash Flow > net Change In Cash

19000

Quarters > 3 > ratios > PE

-0.5208375305748975

Quarters > 3 > ratios > PB

-0.40436150180319425

Quarters > 3 > ratios > ROE

38.29211746522411

Quarters > 3 > ratios > ROA

-162.2816593886463

Quarters > 3 > ratios > FCF

-2731000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-3.2167255594817434

Quarters > 3 > health Score

31

Valuation > metrics > PE

-0.19085119542537116

Valuation > metrics > PB

7.3833652676399035

Valuation > final Score

20

Valuation > verdict

146.1% Overvalued

Profitability > metrics > ROE

-256.2043795620438

Profitability > metrics > ROA

-414.56692913385825

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.06082725060827251

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

0.07912772585669782

Liquidity > metrics > Quick Ratio

0.07912772585669782

Liquidity > final Score

14

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

55

Prev Profitabilities > 1

55

Prev Profitabilities > 2

40

Prev Risks > 0

-1

Prev Risks > 1

-41

Prev Risks > 2

-163

Prev Liquidities > 0

22

Prev Liquidities > 1

24

Prev Liquidities > 2

13

Updated At

2025-12-16T22:26:47.492Z